Stryker

PAHC vs. SYK: Which Stock Is the Better Value Option?

With a short percentage of shares outstanding of 1.63%, Stryker Corporation (NYSE:SYK) is among the 7 Best Longevity and Anti-Aging Stocks to Buy. On June 12, BofA lowered its price target on Stryker Corporation (NYSE:SYK) to $380 from $450 while maintaining a Buy rating on the shares. The firm cited a softer healthcare utilization environment highlighted by its services team and […]

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Stryker Corporation (NYSE:SYK) was among the stocks on Jim Cramer’s radar on Mad Money, as he advised investors to care about where a stock is going, not where it has been. Toward the end of the lightning round, a caller asked if the stock is a buy, sell, or hold. In response, Cramer said: See, […]

Over the last six months, Stryker’s shares have sunk to $310.00, producing a disappointing 11.9% loss - a stark contrast to the S&P 500’s 9.3% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

Wondering if Stryker at around US$312.20 is offering value or just pricing in high expectations already? This article breaks down what the current share price might be implying. The stock is up 2.1% over the past week and 3.3% over the past month, yet is still down 10.3% year to date and has declined 16.5% over the past year, which may have some investors questioning whether recent weakness reflects risk or creates an opening. Recent news around Stryker has focused on its role in the medical...